stomatitis
Information
- Disease name
- stomatitis
- Disease ID
- DOID:9637
- Description
- "A mouth disease that is characterized by inflammation of the mouth and lips." [url:https\://en.wikipedia.org/wiki/Stomatitis]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00001812 | Completed | Phase 3 | A Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Impact of Nystatin on the Development of Oral Irritation in Patients Receiving High Dose Intravenous Interleukin-2 | April 1999 | August 2000 |
| NCT00041665 | Completed | Phase 3 | Recombinant Human Keratinocyte Growth Factor to Reduce Oral Mucositis in Hematologic Malignancy Patients Undergoing Peripheral Blood Stem Cell Transplantation After Radiation and High-dose Chemotherapy | ||
| NCT00051441 | Completed | Phase 3 | Safety & Efficacy Study of Benzydamine Oral Rinse for the Treatment of Oral Mucositis (Mouth Sores) Resulting From Radiation Therapy for Cancer of the Oral Cavity, Oropharynx, or Nasopharynx | February 2005 | |
| NCT00101582 | Completed | Phase 3 | Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer | August 2005 | August 2016 |
| NCT00104065 | Completed | Phase 2 | Safety and Efficacy of CG53135-05 in the Prevention of Oral Mucositis in Patients Receiving Bone Marrow Transplant | January 2005 | December 2005 |
| NCT00323518 | Completed | Phase 2 | A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis | May 2006 | August 2008 |
| NCT00385515 | Completed | Phase 2 | Efficacy of SNX-1012 in the Treatment of Oral Mucositis | June 2006 | July 2008 |
| NCT01837446 | Completed | Phase 2/Phase 3 | Morphine Mouthwash for Management of Oral Mucositis in Patients With Head and Neck Cancer | July 2011 | October 2012 |
| NCT02229136 | Completed | Phase 2 | Miracle Mouthwash Plus Hydrocortisone vs Prednisolone Mouth Rinse for Mouth Sores Caused by Everolimus | September 4, 2014 | November 2022 |
| NCT02407834 | Completed | Phase 4 | Effectiveness of Hygiene Solutions on Denture Biofilm | August 2012 | December 2013 |
| NCT02531906 | Completed | Phase 1 | Gabapentin, Methadone Hydrochloride, and Oxycodone Hydrochloride in Improving Quality of Life in Patients With Stage II-IV Head and Neck Cancer During Chemoradiation | April 24, 2015 | June 14, 2018 |
| NCT02762019 | Completed | Phase 3 | Laser for Oral Mucositis in Pediatric Onco-hematology | September 2013 | October 2015 |
| NCT03200340 | Completed | Phase 2 | EC-18 for Oral Mucositis in Patients With Concomitant Chemoirradiation | July 3, 2018 | May 14, 2021 |
| NCT03469284 | Completed | Phase 2 | MOM's PAIN (Methylene Blue for Oral Mucositis' PAIN) | February 28, 2019 | February 3, 2022 |
| NCT05010928 | Not yet recruiting | Phase 2 | Using Tea-based Mouthwash Relieve Stomatitis and Oral Ulcers | August 26, 2021 | November 26, 2024 |
| NCT06071637 | Recruiting | Phase 3 | Low Power Laser Therapy As Prevention Of Oral Mucositis And Oropharyngeal Pain In Patients Undergoing Allogenetic HSCT | August 1, 2023 | February 28, 2027 |
| NCT05878405 | Recruiting | Phase 3 | Methylene Blue Mouthwash for the Treatment of Oral Mucositis Pain in Patients With Cancer | May 30, 2023 | June 2025 |
| NCT00031551 | Terminated | Phase 2 | Evaluation of Efficacy and Mechanisms of an Antiinflammatory Intervention for Chemotherapy Related Mucosal Injury | March 2002 | August 2010 |
| NCT02326675 | Terminated | N/A | Cryotherapy in the Prevention of Chemotherapy-Induced Mucositis in Stem Cell Transplant | March 2015 | December 2017 |
| NCT00075023 | Terminated | Phase 2 | Effectiveness of Topical Thalidomide to Treat Chronic Graft-Versus-Host-Disease Related Stomatitis | December 2003 | April 2010 |
| NCT01092975 | Terminated | Phase 1 | Safety of Phenylephrine for Oral Mucositis Prevention | March 2010 | April 2011 |
| NCT02945878 | Unknown status | Predictive Factors of Acute Oral Mucositis Induced by Chemo-radiotherapy for Local Advanced Nasopharyngeal Carcinoma | October 2016 | May 2018 | |
| NCT03778008 | Unknown status | Phase 2 | Recombinant Bovine Basic Fibroblast Growth Factor for the Treatment of Radiation Induced Oral Mucositis | December 21, 2018 | December 20, 2019 |
| NCT01099891 | Unknown status | Phase 3 | The Clinical Study for Evaluation of Efficacy and Safety of EGF on Oral Mucositis in Radiation Therapy Patients | March 2010 | December 2015 |
| NCT02735317 | Unknown status | Phase 2 | Efficacy and Safety of FORRAD® for the Management of Radiation-induced Mucositis in Patients With Nasopharyngeal Carcinoma Receiving IMRT | April 2016 | June 2017 |
| NCT05323058 | Unknown status | Phase 2 | The Use of Tulsi Extract for The Management of Oral Mucositis in Head & Neck Cancer Patients Undergoing Radiotherapy | July 2022 | March 2024 |
| NCT01288625 | Withdrawn | Phase 4 | Prospective Study of Head and Neck Cancer Radiation Treatment With or Without Amifostine |
- Disase is a (Disease Ontology)
- DOID:403
- Cross Reference ID (Disease Ontology)
- ICD10CM:K12.1
- Cross Reference ID (Disease Ontology)
- MESH:D013280
- Cross Reference ID (Disease Ontology)
- NCI:C26887
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:95361005
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0038362
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0010280
- MedGen concept unique identifier (MedGen Concept name)
- C0149704
- MedGen unique identifier (MedGen Concept name)
- 508414
- MeSH unique ID (MeSH (Medical Subject Headings))
- D013280